Table 1 Study population.
N | males | females | age | CFHBI | |
|---|---|---|---|---|---|
n and (%) | n and (%) | median and IQR | |||
pwCF: | 272 | 135 (49.6) | 137 (51.4) | 25 (15-36) | 86 (31.6) |
- from Campania | 132 | 60 (45.5) | 72 (54.5) | 29 (17-38) | 31 (23.5) |
- from Tuscany | 140 | 75 (53.6) | 65 (46.4) | 21 (19-33) | 55 (39.3) |
Adult subjects: | 166 | 87 (52.4) | 79 (47.6) | 33 (27-42) | 53 (31.9) |
- F508del homozygous | 61 | 31 (50.8) | 30 (49.2) | 32 (25-38) | 19 (31.1) |
- F508del double heterozygous | 105 | 56 (53.3) | 49 (46.7) | 33 (28-47) | 13 (12.3) |
Pediatric subjects: | 106 | 48 (45.3) | 58 (54.7) | 14 (11-16) | 33 (31.1) |
- F508del homozygous | 45 | 20 (44.4) | 25 (55.6) | 13 (11-16) | 13 (28.9) |
- F508del double heterozygous | 61 | 28 (45.9) | 33 (54.1) | 14 (12-16) | 20 (32.8) |
Adult healthy controls | 166 | 87 (52.4) | 79 (47.6) | 33 (27-42) | |
Pediatric healthy controls | 106 | 48 (45.3) | 58 (54.7) | 14 (11-16) |
